Skip to main content

Advertisement

Log in

CaMKII and CaV3.2 T-type calcium channel mediate Connexin-43-dependent inflammation by activating astrocytes in vincristine-induced neuropathic pain

  • Original Article
  • Published:
Cell Biology and Toxicology Aims and scope Submit manuscript

Abstract

Vincristine (VCR), an alkaloid isolated from vinca, is a commonly used chemotherapeutic drug. However, VCR therapy can lead to dose-dependent peripheral neurotoxicity, mainly manifesting as neuropathic pain, which is one of the dominant reasons for limiting its utility. Experimentally, we discovered that VCR-induced neuropathic pain (VINP) was accompanied by astrocyte activation; the upregulation of phospho-CaMKII (p-CaMKII), CaV3.2, and Connexin-43 (Cx43) expression; and the production and release of inflammatory cytokines and chemokines in the spinal cord. Similar situations were also observed in astrocyte cultures. Interestingly, these alterations were all reversed by intrathecal injection of KN-93 (a CaMKII inhibitor) or l-Ascorbic acid (a CaV3.2 inhibitor). In addition, KN-93 and l-Ascorbic acid inhibited the increase in [Ca2+]i associated with astrocyte activation. We also verified that knocking down or inhibiting Cx43 level via intrathecal injection of Cx43 siRNA or Gap27 (a Cx43 mimetic peptide) relieved pain hypersensitivity and reduced the release of inflammatory factors; however, they did not affect astrocyte activation or p-CaMKII and CaV3.2 expression. Besides, the overexpression of Cx43 through the transfection of the Cx43 plasmid did not affect p-CaMKII and CaV3.2 expressions in vitro. Therefore, CaMKII and CaV3.2 may activate astrocytes by increasing [Ca2+]i, thereby mediating Cx43-dependent inflammation in VINP. Moreover, we demonstrated that the CaMKII signalling pathway was involved in VCR-induced inflammation, apoptosis, and mitochondrial damage. Collectively, our findings show a novel mechanism by which CaMKII and CaV3.2 mediate Cx43-dependent inflammation by activating astrocytes in neuropathic pain induced by VCR.

Graphical abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10

Similar content being viewed by others

Data availability

All data generated or analysed during this study are included in this published article.

References

Download references

Acknowledgements

The authors acknowledge technical and equipment support for this work provided by the Key Laboratory of Pediatrics, Children’s Hospital of Nanjing Medical University.

Funding

This work was supported by Grants from the National Natural Science Foundation of China (No. 81803642 and 82073845), the China Postdoctoral Science Foundation (No. 2019M651903), the National Major Scientific and Technological Special Project for “Significant New Drugs Development” during the Thirteenth Five-year Plan Period (No. 2018ZX09301043-001), and the Jiangsu Research Hospital Association for Precision Medication (No. JY202010).

Author information

Authors and Affiliations

Authors

Contributions

Yunman Li, Yahui Hu, and Feng Chen developed the idea of the study, participated in its design and coordination, and revised the manuscript. Guizhou Li, Yahui Hu, Qingyan Yang, and Di Fu performed the experiments and analysed data. Guizhou Li, Yini Lu, and Yahui Hu drafted the manuscript. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Ya-hui Hu or Yun-man Li.

Ethics declarations

Ethics statement

The animal study was reviewed and approved by Institutional Animal Care and Use Committee of China Pharmaceutical University (Nanjing, China; licence number: SYXK (Su) 2016-0011).

Consent to participate

Not applicable.

Consent for publication

Not applicable.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Highlights

1. CaMKII, CaV3.2, and Cx43 play vital roles in neuropathic pain.

2. CaMKII and CaV3.2 activate astrocytes by mediating calcium ions.

3. CaMKII and CaV3.2 facilitate Cx43-mediated inflammatory factor release in spinal dorsal horn astrocytes.

4. CaMKII mediates VCR-induced inflammation and apoptosis.

Supplementary information

Supplementary S1.

(A, B) The PWT and PWL of mice in sham and sham treated with Gap27 (144 nM) groups. (C, D) The PWT and PWL of mice in sham and sham treated with KN-93 (70 nM) groups. (E, F) The PWT and PWL of mice in sham and sham treated with l-Ascorbic acid (300 μM) groups. ANOVA followed by Tukey’s post hoc test. n = 8 mice/group. All data are represented as means ± SEM. (PNG 429 kb)

High resolution image (TIF 436 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, Gz., Hu, Yh., Lu, Yn. et al. CaMKII and CaV3.2 T-type calcium channel mediate Connexin-43-dependent inflammation by activating astrocytes in vincristine-induced neuropathic pain. Cell Biol Toxicol 39, 679–702 (2023). https://doi.org/10.1007/s10565-021-09631-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10565-021-09631-y

Keywords

Navigation